| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $887K | — | -91.1% |
| R&D Expense | $48.9M | — | -17.2% |
| SG&A Expense | $17.5M | — | -17.3% |
| Operating Income | -$65.5M | — | +6.7% |
| Pre-tax Income | -$60.7M | — | +1.9% |
| Income Tax | $172K | — | +115.8% |
| Net Income | -$60.8M | — | -0.1% |
| EPS (Basic) | -$0.87 | — | +1.1% |
| EPS (Diluted) | -$0.87 | — | +1.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $559.5M | -10.9% | -29.4% |
| Current Assets | $619.1M | -9.3% | -27.7% |
| Total Assets | $652.4M | -9.1% | -26.2% |
| Current Liabilities | $48.9M | -14.2% | -15.2% |
| Total Liabilities | $98.1M | -8.9% | -31.7% |
| Stockholders' Equity | $554.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$65.9M | — | +23.7% |
| Capital Expenditures | $713K | — | +18.0% |
| Investing Cash Flow | -$713K | — | -18.0% |
| Financing Cash Flow | -$54K | — | -31.7% |
| Free Cash Flow | -$66.6M | — | +23.4% |
| -25.1% |